Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ARG1 | P05089 | 3/20 | 0.45 |
| ▸ | ARG2 | P78540 | 3/20 | 0.45 |
| ▸ | ODC1 | P11926 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18274701 | 0.81 | CYP1A2 (0.46) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL19387343 | 0.76 | HTR2C (0.36) | CYP1A2HTR2C | |
| SCHEMBL1434579 | 0.75 | GRM4 (0.35) | HTR2C | |
| SCHEMBL5324175 | 0.74 | MEN1 (0.65) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| Hydrochloric Acid SCHEMBL27995083 | 0.74 | NAAA (0.43) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL16881654 | 0.72 | HTR2C (0.35) | HTR2C | |
| SCHEMBL27832570 | 0.72 | MEN1 (0.53) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL24163861 | 0.72 | MEN1 (0.68) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL6759254 | 0.72 | MEN1 (0.68) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL6759253 | 0.72 | MEN1 (0.68) | MEN1ALDH1A1CYP1A2THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919840-B2 | Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials | SEIKAGAKU CORPORATION (JP) | 2021-02-16 | — | — | US | disclosed |
| EP-3101064-B1 | DIAMINE CROSSLINKING AGENT, ACIDIC POLYSACCHARIDE CROSSLINKED BODY, AND MEDICAL MATERIAL | SEIKAGAKU KOGYO CO LTD (JP) | 2020-07-15 | — | — | EP | disclosed |
| US-20190345312-A1 | DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS | SEIKAGAKU CORPORATION (JP) | 2019-11-14 | — | — | US | disclosed |
| US-10294195-B2 | Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials | SEIKAGAKU CORPORATION (JP) | 2019-05-21 | — | — | US | disclosed |
| US-20170001948-A1 | DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS | SEIKAGAKU CORPORATION (JP) | 2017-01-05 | — | — | US | disclosed |
| EP-3101064-A1 | DIAMINE CROSSLINKING AGENT, ACIDIC POLYSACCHARIDE CROSSLINKED BODY, AND MEDICAL MATERIAL | Seikagaku Corporation (JP) | 2016-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10294195-B2 | Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials | SAT1, ACMSD, ADM2 | MEN1 2165/4885ALDH1A1 293/4885CYP1A2 3928/4885 |
| US-20170001948-A1 | DIAMINE CROSSLINKING AGENTS, CROSSLINKED ACIDIC POLYSACCHARIDES AND MEDICAL MATERIALS | SAT1, ACMSD, ADM2 | MEN1 2165/4885ALDH1A1 293/4885CYP1A2 3928/4885 |
| US-10919840-B2 | Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials | SAT1, ACMSD, ADM2 | MEN1 2165/4885ALDH1A1 293/4885CYP1A2 3928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.